These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20952464)

  • 21. Prevalence of metabolic syndrome in Algerian rheumatoid arthritis patients. Correlation with disease activity and functional status.
    Slimani S; Abbas A; Ben Ammar A; Rahal F; Khider I; Khelif K; Ladjouze-Rezig A
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S425-S427. PubMed ID: 28395950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study.
    Michalsen VL; Wild SH; Kvaløy K; Svartberg J; Melhus M; Broderstad AR
    BMC Cardiovasc Disord; 2021 Oct; 21(1):510. PubMed ID: 34674643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study.
    Karvounaris SA; Sidiropoulos PI; Papadakis JA; Spanakis EK; Bertsias GK; Kritikos HD; Ganotakis ES; Boumpas DT
    Ann Rheum Dis; 2007 Jan; 66(1):28-33. PubMed ID: 16793841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome components and prevalence of cardiovascular disease among type 2 diabetic patients in Malaysia.
    Tan MC; Wong TW; Ng OC; Joseph A; Hejar AR
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):226-35. PubMed ID: 24964674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic Syndrome and Rheumatoid Arthritis Activity: An Analysis of Clinical, Laboratory, and Ultrasound Parameters.
    Grzechnik K; Targońska-Stępniak B
    Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of vitamin D with cardiometabolic risk factors in rheumatoid arthritis.
    Haque UJ; Bathon JM; Giles JT
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1497-504. PubMed ID: 22555877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of cardiorespiratory fitness on classical cardiovascular disease risk factors in rheumatoid arthritis: a cross-sectional and longitudinal study.
    Cooney JK; Ahmad YA; Moore JP; Sandoo A; Thom JM
    Rheumatol Int; 2019 Oct; 39(10):1759-1766. PubMed ID: 31482199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study.
    Elkan AC; Håkansson N; Frostegård J; Cederholm T; Hafström I
    Arthritis Res Ther; 2009; 11(2):R37. PubMed ID: 19284557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome.
    Burggraaf B; van Breukelen-van der Stoep DF; de Vries MA; Klop B; van Zeben J; van de Geijn GM; van der Meulen N; Birnie E; Prinzen L; Castro Cabezas M
    Atherosclerosis; 2018 Apr; 271():84-91. PubMed ID: 29482038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases.
    Abourazzak FE; Mansouri S; Najdi A; Tahiri L; Nejjari C; Harzy T
    Clin Rheumatol; 2014 Nov; 33(11):1549-55. PubMed ID: 24647982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of two metabolic syndrome definitions in the estimation of cardiovascular disease among hypertensive patients.
    Hirota AH; Rodrigues CJ; Borges RL; Ribeiro AB; Zanella MT; Batista MC
    J Clin Hypertens (Greenwich); 2010 Aug; 12(8):588-96. PubMed ID: 20695935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency.
    Qing L; Wei R; Chan L; Xiaoya Z; Xin X
    J Endocrinol Invest; 2017 Jun; 40(6):653-661. PubMed ID: 28233232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis.
    Stavropoulos-Kalinoglou A; Metsios GS; Panoulas VF; Douglas KM; Nevill AM; Jamurtas AZ; Kita M; Koutedakis Y; Kitas GD
    Ann Rheum Dis; 2009 Feb; 68(2):242-5. PubMed ID: 18677010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic cardiovascular risk burden and atherosclerosis in African black and Caucasian women with rheumatoid arthritis: a cross-sectional study.
    Dessein PH; Norton GR; Joffe BI; Abdool-Carrim AT; Woodiwiss AJ; Solomon A
    Clin Exp Rheumatol; 2013; 31(1):53-61. PubMed ID: 22935383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome.
    Gaillard T; Schuster D; Osei K
    Metabolism; 2010 Aug; 59(8):1115-23. PubMed ID: 20051282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factor profiles for atherosclerotic cardiovascular disease in black and other Africans with established rheumatoid arthritis.
    Solomon A; Christian BF; Norton GR; Woodiwiss AJ; Dessein PH
    J Rheumatol; 2010 May; 37(5):953-60. PubMed ID: 20231201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome and 10-year cardiovascular disease incidence: The ATTICA study.
    Kastorini CM; Panagiotakos DB; Georgousopoulou EN; Laskaris A; Skourlis N; Zana A; Chatzinikolaou C; Chrysohoou C; Puddu PE; Tousoulis D; Stefanadis C; Pitsavos C;
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):223-31. PubMed ID: 26803591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Zonana-Nacach A; Santana-Sahagún E; Jiménez-Balderas FJ; Camargo-Coronel A
    J Clin Rheumatol; 2008 Apr; 14(2):74-7. PubMed ID: 18391674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.